Renovorx ceo shaun bagai to present at iaccess alpha virtual best ideas fall investment conference 2025 on september 16th

Mountain view, calif., sept. 11, 2025 (globe newswire) -- renovorx, inc . (“renovorx” or the “company”) (nasdaq: rnxt), a life sciences company developing innovative targeted oncology therapies and commercializing renovocath ® , a patented, fda-cleared drug-delivery device, today announced that shaun bagai, chief executive officer, will present at the iaccess alpha virtual best ideas fall investment conference 2025, held on september 16-17, 2025.
RNXT Ratings Summary
RNXT Quant Ranking